Cargando…

FAK inhibition with small molecule inhibitor Y15 decreases viability, clonogenicity, and cell attachment in thyroid cancer cell lines and synergizes with targeted therapeutics

Focal adhesion kinase (FAK) is up-regulated in thyroid cancer and small molecule FAK scaffolding inhibitor, Y15, was shown to decrease cancer growth in vitro and in vivo. We sought to test the effectiveness of Y15 in thyroid cancer cell lines, profile gene expression with Y15 compared with clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	O'Brien, Shalana, Golubovskaya, Vita M., Conroy, Jeffrey, Liu, Song, Wang, Dan, Liu, Biao, Cance, William G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202172/ https://www.ncbi.nlm.nih.gov/pubmed/25277206

Ejemplares similares

The direct effect of Focal Adhesion Kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis
por: Golubovskaya, Vita M, et al.
Publicado: (2009)

Gene Expression Profiling Identifies Important Genes Affected by R2 Compound Disrupting FAK and P53 Complex
por: Golubovskaya, Vita M., et al.
Publicado: (2014)

Knocking down claudin receptors leads to a decrease in prostate cancer cell migration, cell growth, cell viability and clonogenic cell survival
por: Liu, Qiang, et al.
Publicado: (2021)

Metformin suppresses pediatric acute myeloid leukemia cell viability and clonogenicity
por: Gopalakrishnapillai, Anilkumar, et al.
Publicado: (2014)

Synergism of FAK and ROS1 inhibitors in the treatment of CDH1-deficient cancers mediated by FAK-YAP signaling
por: Gao, Jiaming, et al.
Publicado: (2023)

Inhibition of Hedgehog Signaling Decreases Proliferation and Clonogenicity of Human Mesenchymal Stem Cells
por: Plaisant, Magali, et al.
Publicado: (2011)

Clonogenic Assay of Gastric Adenocarcinoma Stem Cells: Clonogenic Assay, Stomach Cancer
por: Kim, Hoon Kyo, et al.
Publicado: (1987)

Tamoxifen Rechallenge Decreases Metastatic Potential but Increases Cell Viability and Clonogenicity in a Tamoxifen-Mediated Cytotoxicity-Resistant Subline of Human Breast MCF7 Cancer Cells
por: Chang, Yung-Chieh, et al.
Publicado: (2020)

Prexasertib (LY2606368) reduces clonogenic survival by inducing apoptosis in primary patient‐derived osteosarcoma cells and synergizes with cisplatin and talazoparib
por: Heidler, Christopher L., et al.
Publicado: (2019)

CAR-T Cell Therapy: From the Bench to the Bedside
por: Golubovskaya, Vita
Publicado: (2017)

Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability in vitro and impairs tumor growth in vivo
por: Tümmler, Conny, et al.
Publicado: (2017)

Editorial on “Cell Therapy, Bispecific Antibodies and Other Immunotherapies against Cancer”
por: Golubovskaya, Vita
Publicado: (2023)

Effects of Tumor Localization, Age, and Stage on the Outcomes of Gastric and Colorectal Signet Ring Cell Adenocarcinomas
por: Benesch, Matthew G. K., et al.
Publicado: (2023)

Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling
por: Zhang, Baoyuan, et al.
Publicado: (2021)

Inhibition of EIF2α Dephosphorylation Decreases Cell Viability and Synergizes with Standard-of-Care Chemotherapeutics in Head and Neck Squamous Cell Carcinoma
por: Cyran, Anna M., et al.
Publicado: (2023)

Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration
por: Nabissi, Massimo, et al.
Publicado: (2016)

Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways
por: Zhang, Hao, et al.
Publicado: (2016)

Fluorescence discrimination between diploid cells on their RNA content: a possible distinction between clonogenic and non-clonogenic cells.
por: Watson, J. V., et al.
Publicado: (1977)

Malignant Transformation of Long-Standing Ileal Crohn’s Disease Likely Favors Signet Ring Cell Adenocarcinoma Histology
por: Benesch, Matthew G.K., et al.
Publicado: (2023)

Clonogenicity: Holoclones and Meroclones Contain Stem Cells
por: Beaver, Charlotte M., et al.
Publicado: (2014)

Clonogenic cell survival in cryopreserved human tumour cells.
por: Selby, P. J., et al.
Publicado: (1981)

Hydrostatic Compress Force Enhances the Viability and Decreases the Apoptosis of Condylar Chondrocytes through Integrin-FAK-ERK/PI3K Pathway
por: Ma, Dandan, et al.
Publicado: (2016)

Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy
por: Golubovskaya, Vita, et al.
Publicado: (2016)

The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth
por: Kurenova, Elena, et al.
Publicado: (2013)

Epidemiology of Undifferentiated Carcinomas
por: Benesch, Matthew G. K., et al.
Publicado: (2022)

Novel 1,4-Dihydropyridines as Specific Binders and Activators of SIRT3 Impair Cell Viability and Clonogenicity and Downregulate Hypoxia-Induced Targets in Cancer Cells
por: Zwergel, Clemens, et al.
Publicado: (2023)

Enhancement of clonogenicity of human multiple myeloma by dendritic cells
por: Kukreja, Anjli, et al.
Publicado: (2006)

Disruption of focal adhesion kinase and p53 interaction with small molecule compound R2 reactivated p53 and blocked tumor growth
por: Golubovskaya, Vita M, et al.
Publicado: (2013)

Human tumour clonogenicity in agar is improved by cell-free ascites.
por: Uitendaal, M. P., et al.
Publicado: (1983)

Differences of Clonogenic Mesenchymal Stem Cells on Immunomodulation of Lymphocyte Subsets
por: Martínez-Peinado, Pascual, et al.
Publicado: (2018)

Robustness of Clonogenic Assays as a Biomarker for Cancer Cell Radiosensitivity
por: Matsui, Toshiaki, et al.
Publicado: (2019)

Editorial on Special Issue “Immunotherapy, Tumor Microenvironment and Survival Signaling”
por: Golubovskaya, Vita
Publicado: (2021)

Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia
por: Shi, Pei-Jie, et al.
Publicado: (2016)

Effect of host-cell interactions on clonogenic carcinoma cells in human malignant effusions.
por: Buick, R. N., et al.
Publicado: (1980)

Natural killer cells efficiently target multiple myeloma clonogenic tumor cells
por: Leivas, Alejandra, et al.
Publicado: (2021)

An artefact in clonogenic assays of bleomycin cytotoxicity.
por: Twentyman, P. R.
Publicado: (1977)

T cell receptor- and beta 1 integrin-mediated signals synergize to induce tyrosine phosphorylation of focal adhesion kinase (pp125FAK) in human T cells
Publicado: (1995)

SEMA6C: a novel adhesion-independent FAK and YAP activator, required for cancer cell viability and growth
por: Fard, Damon, et al.
Publicado: (2023)

A comparison of human tumour-cell clonogenicity in methylcellulose and agar culture.
por: Buick, R. N., et al.
Publicado: (1980)

Ovarian carcinoma cells in culture: assessment of drug sensitivity by clonogenic assay.
por: Simmonds, A. P., et al.
Publicado: (1984)

Cannot write session to /tmp/vufind_sessions/sess_t84gpvhisarqoqhpf8s1jqcm8i